Investment bankers embrace ‘intense’ pitching as groups in defence, tech and wider economy prepare to go public ...
Fast-forward to 2026, and we’ve already seen a handful of U.S. biotechs line up to squeeze through a gradually reopening IPO ...
Shadowfax Technologies IPO saw strong demand with a subscription status of 2.72x. The allotment date was January 23, and ...
The valuation increased threefold since its last valuation in 2023.
The debut signals a shift for digital asset infrastructure, with Goldman Sachs and Citigroup leading the underwriting ...
By Echo Wang and Prakhar Srivastava Jan 22 (Reuters) - Elon Musk's space startup SpaceX is lining up four Wall Street banks ...
Armored vehicle and munitions maker Czechoslovak Group is set to start trading in Amsterdam on Friday morning, after the firm ...
Ethos was backed by a who's who of VCs and celebs through 2021. It is currently profitable, it says.
VanEck analyst calls it a "superior asset" within its valuation range.
SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...
The four Wall Street firms are currently selling existing shares valuing the company at $800 billion, according to reports.
The largest ever defense initial public offering surged in its debut in Amsterdam on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results